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The second most frequent cause of autosomal recessive Parkinson’s disease is rep-
resented by mutations in the PTEN-induced putative kinase1 (PINK1). The PINK1 
protein mainly localizes to mitochondria which are considered the target organelles 
mainly affected in Parkinson’s disease. In fact, parkinsonism-inducing neurotoxins 
such as rotenone, MPTP and methamphetamine all damage mitochondria. There-
fore, the ability to counteract mitochondrial toxicity and promoting mitochondrial 
renewal by mithophagy and mitochondrial biogenesis is critical to cure Parkinsonism. 
For instance the autophagy-dependent removal of altered mitochondria known as 
mitophagy is supposed to be key in conteracting mitochondrial toxicity. Interestingly 
mitochondrial PINK1 is known to interact with autophagy proteins such as beclin1 
and the ubiquitin-ligase parkin. Therefore, in the present study we evaluated whether 
such an interaction produced downstream effects leading to autophagy activation. 
This was evaluated through the simultaneous analysis of co-localization of parkin 
and beclin1 with the autophagy initiator ubiquitin. These phenomena were analyzed 
both at mitochondrial level and throughout the cytosol by analyzing autophagy-like 
vacuoles and LC3-II positive structures. Interestingly, despite increased mitophagy 
PINK1 overexpression did not produce a general activation of the autophagy path-
way. It is likely that such a selective fashion of autophagy activation only limited to 
mitochondrial removal could explain the relevance of PINK1 for Parkinson’s disease 
but not for other neurodegenerative, autophagy-related disorders. The present data 
were obtained through several experimental settings featuring PINK1 overexpression, 
mutation, deletion and silencing of the gene. The effects were analyzed in baseline 
conditions but were supplemented by experiments in the presence of methampheta-
mine used here both as a mitochondrial neurotoxin and an autophagy-dependent 
Parkinsonism inducing compound. Data revealed that PINK1 was critical for mito-
chondria and cell viability already in baseline conditions though such an effect was 
magnified upon methamphetamine exposure. The present findings while explaining 
the molecular interactions which are likely to induce PINK1-dependent genetic Par-
kinsonism, provide a further evidence on the critical role of genetic and environmental 
alterations in the genesis of Parkinson’s disease.
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